Form 4: H.B. Fuller CFO Acquires Phantom Units
Insider Trading Report
H.B. Fuller's Executive VP and CFO, John J. Corkrean, reported the acquisition of 164.38 phantom units under a pre-arranged plan.
Summary
- John J. Corkrean, Executive VP and CFO of H.B. Fuller Co. (FUL), reported changes in beneficial ownership.
- On November 21, 2025, Corkrean acquired 164.38 phantom units.
- These phantom units convert into shares of common stock on a 1-for-1 basis and include dividend equivalents.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction.
- Following this transaction, Corkrean beneficially owns 54,646 shares of common stock directly and 27,527.56 phantom units.
- The filing also details various employee stock options and restricted stock units held by Corkrean, including options with exercise prices ranging from $45.05 to $77.72 and restricted stock units vesting in annual installments.
Sentiment
Score: 6
Explanation: The acquisition of phantom units by a key executive is a routine compensation event, slightly positive as it aligns executive interests with shareholders, but not a significant market moving event for the company's stock price.
Positives
- The acquisition of phantom units by a key executive aligns their interests with shareholders, potentially fostering long-term value creation.
- The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-scheduled, non-discretionary transaction rather than a discretionary market timing move.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
This filing is a routine insider transaction report, common across all publicly traded companies, and does not provide specific industry context beyond H.B. Fuller's operations as a global manufacturer of adhesives, sealants, and specialty chemicals.
Related Party Transactions
- The acquisition of phantom units by Executive VP and CFO John J. Corkrean is a related party transaction as it involves an executive of the company receiving compensation in the form of equity-linked instruments.
Stakeholder Impact
- Shareholders: The acquisition of phantom units by a key executive generally aligns management's interests with shareholders, potentially fostering long-term value creation.
- Employees: This transaction is part of an executive compensation plan, which can influence overall compensation strategies within the company.
Next Steps
- Phantom units will convert into common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
- Remaining unvested employee stock options and restricted stock units will vest according to their respective schedules.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Grant date for Employee Stock Option with exercise price $50.1, 100% vested, expiring 01/26/2027. |
| 01/25/2019 | Grant date for Employee Stock Option with exercise price $53.57, 100% vested, expiring 01/25/2028. |
| 01/24/2020 | Grant date for Employee Stock Option with exercise price $45.05, 100% vested, expiring 01/24/2029. |
| 01/24/2021 | Grant date for Employee Stock Option with exercise price $48.35, 100% vested, expiring 01/24/2030. |
| 01/27/2022 | Grant date for Employee Stock Option with exercise price $51.89, 100% vested, expiring 01/27/2031. |
| 01/24/2023 | Grant date for Employee Stock Option with exercise price $72.94, 100% vested, expiring 01/24/2032. |
| 01/24/2024 | Grant date for Employee Stock Option with exercise price $68.17, vesting in three annual installments, expiring 01/24/2033. Also, vesting start date for Restricted Stock Units (1,302.35 units) expiring 01/24/2026. |
| 01/26/2025 | Grant date for Employee Stock Option with exercise price $77.72, vesting in three annual installments, expiring 01/26/2034. Also, vesting start date for Restricted Stock Units (2,852.64 units) expiring 01/26/2027. |
| 01/27/2026 | Grant date for Employee Stock Option with exercise price $64.28, vesting in three annual installments, expiring 01/27/2035. Also, vesting start date for Restricted Stock Units (4,370.58 units) expiring 01/27/2028. |
| 11/21/2025 | Transaction date for the acquisition of 164.38 phantom units. |
| 11/24/2025 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing reports a routine, compensation-related acquisition of phantom units by a key executive under a pre-arranged plan. While it indicates continued alignment of management's interests with shareholders, it does not provide new fundamental information about the company's performance or strategic direction that would warrant a change in investment recommendation. It's a standard disclosure of executive compensation.
Keywords
H.B. Fuller, FUL, John J. Corkrean, SEC Form 4, Insider Transaction, Phantom Units, Executive Compensation, Beneficial Ownership, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.